Australia Proposes More Proportionate Sanctions And Penalties
Australia’s Therapeutics Goods Administration wants to introduce an “effective layered approach to compliance and enforcement” for breaches of advertising and other rules.
You may also be interested in...
New medicines under evaluation at the European Medicines Agency.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.
GenSight Biologics believes Lumevoq could become the first curative treatment for Leber hereditary optic neuropathy.